OR26-02 VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor In Development For Thyroid Eye Disease (TED), Binds To A Distinct Epitope From Teprotumumab

por Bedian, Vahe, Tsai, Jordan C, Newell, Rachel N, Zhao, Yang
Publicado 2023

Selection of chromosomal DNA libraries using a multiplex CRISPR system

por Ryan, Owen W, Skerker, Jeffrey M, Maurer, Matthew J, Li, Xin, Tsai, Jordan C, Poddar, Snigdha, Lee, Michael E, DeLoache, Will, Dueber, John E, Arkin, Adam P, Cate, Jamie HD
Publicado 2014

Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response

por Sidrauski, Carmela, Tsai, Jordan C, Kampmann, Martin, Hearn, Brian R, Vedantham, Punitha, Jaishankar, Priyadarshini, Sokabe, Masaaki, Mendez, Aaron S, Newton, Billy W, Tang, Edward L, Verschueren, Erik, Johnson, Jeffrey R, Krogan, Nevan J, Fraser, Christopher S, Weissman, Jonathan S, Renslo, Adam R, Walter, Peter
Publicado 2015

Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models

por Wang, Feng, Tsai, Jordan C., Davis, Jonathan H., Chau, Bryant, Dong, Jia, West, Sean M., Hogan, Jason M., Wheeler, Matthew L., Bee, Christine, Morishige, Winse, Cayton, Thomas, David-brown, Donata, Zhang, Chengyue, Kozhich, Alexander, Sproul, Tim, Dollinger, Gavin, Rajpal, Arvind, Strop, Pavel
Publicado 2019